Back to TARS
Cambridge Investment Research Advisors, Inc. → TARS
Cambridge Investment Research Advisors, Inc. TARS Position History
Tarsus Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$863K
Q3 2026
Peak value
$1.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $894K |
| Q4 2025 | $1.2M |
| Q1 2026 | $896K |
| Q2 2026 | $898K |
| Q2 2026 | $898K |
| Q3 2026 | $863K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $863K | 11.0K | — | — |
| Q2 2026 | $898K | 14.3K | — | — |
| Q2 2026 | $898K | 14.3K | — | — |
| Q1 2026 | $896K | 12.8K | — | — |
| Q4 2025 | $1.2M | 15.2K | — | — |
| Q3 2025 | $894K | 15.1K | — | — |
Other funds holding TARS
$155.5M
$126.3M
$105.9M
$101.3M